Pathological Complete Response with Neoadjuvant Trastuzumab Combined with Chemotherapy in HER2 Positive Breast Cancer: A Single Institution Retrospective Analysis from Vietnam

PURPOSE: Neoadjuvant regimens containing trastuzumab and chemotherapy were widely used in human epidermal growth factor 2 (HER2) positive breast cancer patients. In this article, we report complete pathological response (pCR) rates from a single institution in Vietnam. PATIENTS AND METHODS: Medical...

Descripción completa

Detalles Bibliográficos
Autores principales: Phung, Huyen Thi, Nguyen, Hoa Thi, Nguyen, Tung Van, Nguyen, Tai Van, Dinh, Lan Anh Thi, Nguyen, Chu Van
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549132/
https://www.ncbi.nlm.nih.gov/pubmed/33116813
http://dx.doi.org/10.2147/BCTT.S268369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549132/
https://www.ncbi.nlm.nih.gov/pubmed/33116813
http://dx.doi.org/10.2147/BCTT.S268369

Ejemplares similares